Evaluation of a type 2 diabetes screening protocol in an urban pediatric clinic

Stephanie Drobac1, Wendy Brickman, Tiy Smith

  • 1Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. sdrobac@peds.bsd.uchicago.edu

Pediatrics
|July 3, 2004
PubMed

Insights

The American Diabetes Association type 2 diabetes screening protocol was inconsistently applied in an urban pediatric clinic, with acanthosis nigricans a key factor in identifying children for screening. Early identification is crucial for managing pediatric diabetes.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Clinical Research

Background:

  • The American Diabetes Association (ADA) established guidelines in 2000 for screening type 2 diabetes mellitus (T2DM) in children.
  • Recommendations include testing children aged 10 years or older with a BMI at or above the 85th percentile for age, plus at least two risk factors.

Purpose of the Study:

  • To evaluate the implementation of the ADA's T2DM screening protocol within an urban pediatric clinic setting.
  • To describe the characteristics of the pediatric population screened and the application of the protocol.

Main Methods:

  • A retrospective review of medical records for 997 patients aged 10-18 years during a 13-month period.
  • Data collection included demographics, medical/family history, physical exams, counseling, and laboratory results.
  • Body Mass Index (BMI) percentiles were calculated using national references.

Main Results:

  • Nearly half (48%) of the subjects had a BMI at or above the 85th percentile, with 96% being Hispanic.
  • Only 41% of eligible subjects met the criteria for T2DM screening.
  • Screening was ordered for 38% of eligible patients, with acanthosis nigricans being a significant factor in identification.

Conclusions:

  • The ADA T2DM screening protocol was inconsistently applied at this high-risk urban clinic.
  • Acanthosis nigricans played a crucial role in identifying patients for screening.
  • Screening was associated with increased nutritional counseling documentation, highlighting the need for further research on protocol effectiveness.
Abstract

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...